NWBO
NORTHWEST BIOTHERAPEUTICS INC
Key Financials
Operating Income
$-59914000
↑ 9.9%
Revenue
$1.4M
↓ 0.3%
Net Income
$-60162000
↑ 28.2%
EPS (Diluted)
$-0.04
↑ 42.9%
Total Assets
$81.3M
↑ 204.1%
Total Liabilities
$128.9M
↑ 21.9%
Shareholders' Equity
$-60280000.00
↑ 36.2%
Cash & Equivalents
$3.0M
↑ 39.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/14/2026 | View on SEC |
| 8-K | 7/31/2026 | View on SEC |
| 424B5 | 7/31/2026 | View on SEC |
| 8-K | 7/20/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
| EFFECT | 4/20/2026 | View on SEC |
| POS AM | 4/16/2026 | View on SEC |
| 10-K | 4/15/2026 | View on SEC |
| 8-K | 4/7/2026 | View on SEC |
| NT 10-K | 3/31/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NWBO |
| Company Name | NORTHWEST BIOTHERAPEUTICS INC |
| CIK | 1072379 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (240) 497-9024 |